3 November 2026

Disclosure of trading in own shares

under a share buyback program

Period: From 26 to 30 October 2026

Issuer’s registered name: Ipsos

Issuer’s Identification code: 9695002OY2X35E9X8W87

Financial instrument reference: Ordinary shares – ISIN code FR0000073298

Reporting of transactions in aggregated form (per day and per trading venue)

Issuer name Issuer Code Transaction date ISIN Code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform
      ISIN code (ISO 6166)     MIC code (ISO 10383)
IPSOS 9695002OY2X35E9X8W87 26-Oct-26 FR0000073298 11 997 35,4441 XPAR
IPSOS 9695002OY2X35E9X8W87 26-Oct-26 FR0000073298 3 000 35,4426 CEUX
IPSOS 9695002OY2X35E9X8W87 27-Oct-26 FR0000073298 11 266 35,4987 XPAR
IPSOS 9695002OY2X35E9X8W87 27-Oct-26 FR0000073298 3 712 35,4510 CEUX
IPSOS 9695002OY2X35E9X8W87 28-Oct-26 FR0000073298 8 576 35,7801 XPAR
IPSOS 9695002OY2X35E9X8W87 28-Oct-26 FR0000073298 7 677 35,5758 CEUX
IPSOS 9695002OY2X35E9X8W87 29-Oct-26 FR0000073298 10 000 35,5716 XPAR
IPSOS 9695002OY2X35E9X8W87 29-Oct-26 FR0000073298 5 250 35,5408 CEUX
IPSOS 9695002OY2X35E9X8W87 30-Oct-26 FR0000073298 7 415 35,4041 XPAR
IPSOS 9695002OY2X35E9X8W87 30-Oct-26 FR0000073298 5 941 35,3270 CEUX

Detailed presentation by transaction

A detailed presentation by transaction is available on the Company’s website (www.ipsos.com), in the section on regulated information, in the chapter entitled: “Share buyback programs and share buyback declarations”: https://www.ipsos.com/en/regulated-informations/en.

Attachment

Preclinical data support the potential of PoxSTG-EEV to overcome key barriers to systemic (IV) delivery and enhance tumor dissemination of oncolytic viruses

Strasbourg, France, November 3, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that new preclinical data on PoxSTG-EEV, its novel enveloped chimeric oncolytic virus, have been selected for a poster presentation at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting.
SITC will take place November 4 – 8, 2026, in Phoenix, Arizona (USA).

These data highlight the potential of PoxSTG-EEV, a next-generation chimeric oncolytic virus with a novel Extracellular Enveloped Virion (EEV) formulation developed by Transgene to enhance intratumoral dissemination and increase resistance to immune-mediated neutralization, supporting its potential for systemic (IV) administration.

“Oncolytic viruses have shown considerable promise in cancer treatment, however their full therapeutic potential could be further enhanced by improvements related to systemic delivery and intratumoral spread,” said Katell Bidet-Huang, Chief Scientific Officer ad interim at Transgene. “These preclinical findings demonstrate the potential of PoxSTG-EEV to address some of these barriers and highlight the continued innovation from Transgene’s viral vector expertise.”

“PoxSTG-EEV combines the PoxSTG chimeric viral vector backbone, with an EEV-enriched formulation designed to generate and preserve the EEV form of the virus and serves as the backbone for Transgene’s proprietary EEVOLVTM platform, supporting the development of a new generation of poxvirus-based-clinical candidates” added Johann Foloppe, PhD, Senior scientist and Project leader at Transgene.

Preclinical studies showed that compared with conventional oncolytic vaccinia viruses, PoxSTG-EEV enhanced cytotoxic activity across multiple tumor cell lines and intratumoral dissemination, while maintaining infectivity in the presence of active complement and neutralizing antibodies. In mouse models, intravenous administration significantly reduced tumor growth and prolonged survival.

Poster Details

Title: “PoxSTG-EEV: a Novel Enveloped Virion – Based Formulation of a Chimeric Oncolytic PoxVirus Adapted for Systemic Delivery”

  • Abstract number: 1050
  • Date: November 7, 2026
  • Authors: Johann Foloppe, Juliette Kempf, Michèle Klein, Julie Hortelano, Baptiste Moreau, Laurine Gault, Isabelle Farine, Philippe Erbs

The poster will be available on the websites of SITC and Transgene on November 7, 2026, at 9:00 a.m. ET.

***

Contacts

Transgene:  
Media: Investors & Analysts:
Caroline Tosch-Pourchot Lucie Larguier
Corporate and Scientific Communications Manager Chief Financial Officer (CFO)
+33 (0)3 68 33 27 38 +33 (0)3 88 27 91 00/21
communication@transgene.fr investorrelations@transgene.fr
   
MEDiSTRAVA  
Frazer Hall/Sylvie Berrebi  
+ 44 (0)203 928 6900  
transgene@medistrava.com  


About Transgene
Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing virus-based targeted immunotherapies and vaccines. The Company’s clinical-stage programs consist of a portfolio of viral vector-based immunotherapeutics. Transgene’s myvac® platform is designed to develop individualized neoantigen therapeutic vaccines (INTVs), with potential across multiple solid tumor types.
TG4050, the first INTV based on the myvac® platform is the Company’s lead asset, with demonstrated clinical proof of principle in the adjuvant treatment of head and neck cancer. TG4070, the second myvac®-based INTV introduces Transgene’s proprietary AI-driven neoantigen selection and scalable cell-line manufacturing capabilities and is in Phase 1 clinical development in combination with nivolumab in the adjuvant treatment of non-small cell lung cancer (NSCLC). The Company’s other viral vector-based assets include BT-001, an oncolytic virus based on the Invir.IO® viral backbone, which is in clinical development. Transgene also conducts innovative discovery and preclinical work, aimed at developing novel viral vector-based modalities.
With Transgene’s myvac® platform, therapeutic vaccination enters the field of precision medicine with an immunotherapy tailored to each individual patient. The myvac® approach enables the generation of virus-based immunotherapies encoding patient-specific neoantigens. Transgene has further expanded the platform’s capabilities with its own proprietary AI-driven neoantigen selection and scalable cell-line manufacturing.
Leveraging its MVA and cell-line manufacturing expertise, Transgene is developing TG-MVA™, a next-generation prophylactic vaccine candidate against mpox and smallpox designed to address key manufacturing and supply challenges.
Transgene is building on its viral vector engineering expertise to design a new generation of multifunctional oncolytic viruses.
Additional information about Transgene is available at: www.transgene.com
Follow us on social media: LinkedIn: @Transgene — X: @TransgeneSA — Bluesky: @Transgene

Disclaimer
This press release contains forward-looking statements, which are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. The occurrence of any of these risks could have a significant negative outcome for the Company’s activities, perspectives, financial situation, results, regulatory authorities’ agreement with development phases, and development. The Company’s ability to commercialize its products depends on but is not limited to the following factors: positive pre-clinical data may not be predictive of human clinical results, the success of clinical studies, the ability to obtain financing and/or partnerships for product manufacturing, development and commercialization, and marketing approval by government regulatory authorities. For a discussion of risks and uncertainties which could cause the Company’s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (“Facteurs de Risque”) section of the Universal Registration Document, available on the AMF website (http://www.amf-france.org) or on Transgene’s website (www.transgene.com). Forward-looking statements speak only as of the date on which they are made, and Transgene undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future.

Attachment

Paris (France), November 3, 2026

2026 third-quarter results
Solid cash generation and continued deleveraging
Further evidence of commercial recovery

  • Net Cash Flow of $35m in Q3, bringing 9M 2026 to $67m vs $62m in 9M 2025, supported by Geoscience’s performance and working-capital normalization
  • Net Debt (excluding IFRS 16) of $656m at end-September, down -18% year on year. A further partial early redemption of the bond, targeting the euro-denominated tranche, has been announced for November, supporting the Group’s deleveraging trajectory
  • Geoscience returned to growth, with revenue of $112m, up +3% year on year and +17% sequentially, reflecting strong execution and backlog conversion. Commercial momentum remains healthy, supported by sustained customer engagement
  • Earth Data revenue of $69m, down -49% year on year, reflecting a high comparison base with Q3 2025, which benefited from exceptional transfer fees. Commercial momentum continues to build across frontier basins, while year-to-date E&P performance provides a supportive backdrop for Q4 revenue
  • Sensing & Monitoring revenue of $56m, down -18% year on year, still negatively impacted by the ongoing conflict in the Middle East. An operational review is underway to further strengthen the business and position it to capture growth opportunities as market conditions recover
  • Segment adjusted EBITDAs of $100m, down -40% year on year, largely due to the significant contribution from the exceptional transfer fees in Q3 2025
  • FY 2026 Net Cash Flow objective of $100m confirmed

Henning Berg, CEO of Viridien: “While market conditions remain uneven across our businesses, I am particularly pleased with Geoscience’s performance, which returned to growth as strong execution translated backlog into revenue. Solid cash generation during the quarter and continued deleveraging also underline our focus on further strengthening the Group’s financial position. Overall, sector sentiment continues to improve. Looking ahead, stronger customer engagement and sustained commercial activity reinforce our confidence in a more supportive market environment in Q4, with further momentum expected into 2027”.

(in millions of $)1 Q3 2026 Q3 2025 Change (%) 9M 2026 9M 2025 Change (%)
Segment figures            
Revenue 237 313 -24% 683 888 -23%
Adjusted EBITDAs 100 167 -40% 268 417 -36%
IFRS figures            
Revenue 236 266 -12% 771 758 +2%
EBITDAs 98 120 -18% 348 287 +21%
Operating Income 13 77 -84% 25 149 -83%
Net Income -10 41 n.a. -46 19 n.a.
Net Cash Flow 35 53 -33% 67 62 +8%
Net Debt2 (excluding IFRS 16) 656 804 -18% 656 804 -18%

KEY HIGHLIGHTS PER BUSINESS LINE3

Data, Digital and Energy Transition (DDE): GEO back to growth, EDA outlook encouraging

Segment Revenue of $181m

Geoscience (GEO)

  • Revenue of $112m, up +3% year on year
  • Q3 revenue increased 17% sequentially, reflecting effective backlog execution. Activity remained robust in mature basins, including the U.S. Gulf and Mexico, where Geoscience delivered major high-end reprocessing projects for IOCs and regional NOCs seeking to unlock new exploration opportunities in a capital-efficient manner. Emerging areas such as Guyana also remained very active
  • Commercial activity remains dynamic, with the cumulative value of pending bids (i.e. tenders for which proposals have either been submitted and are awaiting award, or are currently being prepared) up by a high double-digit percentage year on year, supporting the outlook for order intake over the coming months. Backlog stood at $267m at end-September 2026 and increased to $283m at end-October 2026, with additional verbal awards not yet formalized representing several tens of millions of dollars
  • Computing capacity reached 765 petaflops at end-September 2026, up +21% year on year. Productivity per employee increased to $409k, compared with $374k one year earlier (+9%)

Earth Data (EDA)

  • Revenue of $69m, down -49% year on year, reflecting both the impact of exceptionally high transfer fees recorded in Q3 2025 and lower prefunding revenue. Earth Data capital expenditure amounted to $36m in Q3, down -20% year on year, reflecting changes in the phasing of certain projects. Late sales were satisfactory and remained in line with normal seasonal levels
  • Cash EBITDA of $19m vs $73m in Q3 2025, again reflecting an exceptionally strong prior-year comparison driven by significant transfer fees

Segment adjusted EBITDAs of $112m, representing a 62% margin, the highest quarterly level in 2026, with GEO profitability improving both sequentially and year on year.

Sensing and Monitoring (SMO): Market conditions remain challenging

Segment Revenue of $56m, down -18% year on year, as geopolitical uncertainty in the Middle East continued to weigh on market activity.

Segment adjusted EBITDAs of -$5m and Segment adjusted Operating Income of -$11m.

With geopolitical uncertainty continuing to weigh on SMO, Viridien has initiated an operational review to further to further adapt SMO’s operating model and lower its break-even point, while preserving the capabilities required to capture future opportunities as market conditions recover.

CONSOLIDATED IFRS FIGURES4

Profit & Loss: Marginal IFRS 15 timing impact in Q3 2026

Consolidated IFRS revenue reached $236m in Q3 2026, including a marginal -$2m IFRS 15 timing impact on revenue recognition. IFRS EBITDAs stood at $98m, reflecting a similarly limited adjustment. IFRS net income was -$10m, mainly reflecting -$73m of depreciation and amortization (including -$65m related to Earth Data projects), -$10m of IFRS 16 lease-related expenses, -$23m in net cost of financial debt, and a +$1m contribution from income taxes.

(in millions of $) Q3 2026 Q3 2025 Change (%) 9M 2026 9M 2025 Change (%)
€/$ exchange rate 1.16  1.16 0% 1.17  1.11 +6%
Revenue 236 266 -12% 771 758 +2%
EBITDAs 98 120 -18% 348 287 +21%
Operating Income 13 77 -84% 25 149 -83%
Equity from investment 0 0 n.s. 0 -1 n.a.
Net cost of financial debt -23 -27 -14% -72 -79 -10%
Other financial income (loss) 0 -1 n.a. -1 -35 -98%
Income taxes 1 -9 n.a. 0 -16 n.a.
Net Income (loss) from continuing operations -10 41 n.a. -47 17 n.a.
Net Income (loss) from discontinued operations 0 1 n.a. 1 3 -55%
Consolidated Net Income (loss) -10 41 n.a. -46 19 n.a.

Cash Flow Statement and Debt: Continued Net Cash Flow generation

Net Cash Flow reached $35m in Q3 2026, supported by solid execution by GEO and the normalization of working capital. During the quarter, Viridien successfully collected all outstanding unpaid receivables from PEMEX, the Mexican national oil company. Year-to-date Net Cash Flow reached $67m at end-September 2026, compared with $62m generated over the same period in 2025.

(in millions of $) Q3 2026 Q3 2025 Change (%) 9M 2026 9M 2025 Change (%)
Segment EBITDAs 100 167 -40% 260 417 -38%
Income tax paid -5 -6 -7% -12 -14 -12%
Change in working capital & provisions 1 -36 n.a. 22 -82 n.a.
Other cash items 1 0 n.a. 10 -1 n.a.
Cash from Operating Activity 97 125 -23% 280 320 -13%
Total capex -47 -54 -12% -138 -173 -20%
Acquisitions and proceeds of assets 2 1 +40% 4 2 +77%
Cash from Investing Activity -46 -53 -13% -134 -171 -21%
Paid cost of debt 0 -1 n.a. -40 -41 -3%
Lease repayment -16 -18 -13% -41 -44 -7%
Other financing activities 0 0 n.a. 3 -1 n.a.
Cash from Financing Activity -16 -19 -20% -78 -86 -9%
Discontinued operations acquisitions 0 -1 n.a. 0 -1 n.a.
Net Cash Flow 35 53 -33% 67 62 +8%
Refinancing costs paid (fees + call premium) 0 0 n.a. -1 -42 -97%
Repayment and issuance of debt -2 9 n.a. -36 -104 -66%
Forex and other 0 3 n.a. 2 8 -77%
Net increase (decrease) in Cash 33 65 -49% 32 -75 n.a.

Net Debt (excluding IFRS 16) declined to $656m at end-September 2026, compared with $735m at end-December 2025 and $804m at end-September 2025. Viridien remains firmly focused on deleveraging, with Net Cash Flow generation primarily allocated to debt reduction. Consistent with this strategy, and in accordance with the terms of its bond documentation, the Group has announced a new partial early bond redemption for November, targeting the euro-denominated tranche.

As of September 30, 2026, Viridien maintained a strong liquidity position, including a $125m RCF5.

(in millions of $) Sep. 30,
2026
Dec. 31, 2025 Change
(%)
Sep. 30,
2025
Change
(%)
Liquidity 305 273 +12% 327 -7%
Cash 205 173 +18% 227 -10%
Undrawn RCF 100 100 0% 100 0%
Gross Debt 1,009 1,043 -3% 1,156 -13%
Bonds 8406 895 -6% 988 -15%
Other borrowings 21 13 +59% 42 -51%
Lease liabilities 148 135 +10% 126 +18%
Net Debt7 (including IFRS 16) 805 870 -8% 929 -13%
Net Debt7 (excluding IFRS 16) 656 735 -11% 804 -18%

OUTLOOK

Viridien continues to see improving commercial momentum across frontier basins, with further signs that the offshore investment cycle is entering a recovery phase. E&P companies are advancing projects and positioning to secure new acreage, supporting demand for legacy-data reprocessing and selective new data acquisition. Meanwhile, mature basins continue to provide solid opportunities for high-end imaging and reservoir optimization, supported by renewed investment driven by natural field depletion and increasing energy security requirements.

Overall sector sentiment is increasingly positive, with stronger customer engagement and sustained commercial activity supporting the Group’s confidence in a more favorable market environment in Q4 and further momentum into 2027.

Viridien confirms its FY 2026 Net Cash Flow objective of $100m.

***

Q3 2026 conference call details

The press release and presentation will be made available on www.viridiengroup.com at 5:45 p.m. (CET).

An English-language conference call is scheduled today at 6:00 p.m. (CET).

Participants must register for the conference call by clicking here to receive a dial-in number and PIN code. Participants may also join the live webcast by clicking here.

A replay of the conference call will also be available, for a period of 12 months, on the Company’s website www.viridiengroup.com

Status of the Statutory Auditors’ procedures

The Board of Directors met on November 3, 2026, and closed the consolidated financial statements as of September 30, 2026. Please note that the figures and information published in this press release have not been audited nor subject to any limited review by Viridien’s statutory auditors.

Next financial information

2026 full-year results: February 25, 2027 (after market close)

About Viridien

Viridien (www.viridiengroup.com) is an advanced technology, digital and Earth data company that pushes the boundaries of science for a more prosperous and sustainable future. With our ingenuity, drive and deep curiosity we discover new insights, innovations, and solutions that efficiently and responsibly resolve complex natural resources, digital, energy transition and infrastructure challenges. Viridien employs around 3,000 people worldwide and is listed as VIRI on the Euronext Paris SA (ISIN: FR001400PVN6).

Disclaimer

Certain information included in this press release is not historical data but forward-looking statements. These forward-looking statements are based on current beliefs and assumptions, including, but not limited to, assumptions about current and future business strategies and the environment in which Viridien operates, and involve known and unknown risks, uncertainties and other factors, which may cause actual results or performance, or the results or other events, to be materially different from those expressed or implied in such forward-looking statements. These risks and uncertainties include those discussed or identified in Chapter 2 “Risk Management and Internal Control” of the Universal Registration Document dated April 2, 2026, filed with the French Financial Markets Authority (AMF) under number D. 26-0211 and available on the Group’s website (www.viridiengroup.com) and on the AMF website (www.amffrance.org). These forward-looking statements and information are not guarantees of future performance. Forward-looking statements speak only as of the date of this press release. This press release does not contain or constitute an offer of securities or an invitation or inducement to invest in securities in France, the United States, or any other area.

Investors contact

VP Investor Relations and Corporate Finance
Alexandre Leroy
alexandre.leroy@viridiengroup.com
+33 6 85 18 44 31

Media contact

Brunswick
Aurélia de Lapeyrouse – +33 6 21 06 40 33
Hugues Boëton – +33 6 79 99 27 15
Tristan Roquet Montégon – +33 6 37 00 52 57
viridien@brunswickgroup.com

APPENDICES

Quarterly financial statements are unaudited and not subject to any review.

Key Segment P&L figures

(in millions of $) Q3 2026 Q3 2025 Change (%) 9M 2026 9M 2025 Change (%)
€/$ exchange rate 1.16 1.16 0% 1.17 1.11 +6%
Segment Revenue 237 313 -24% 683 888 -23%
DDE 181 244 -26% 505 639 -21%
Geoscience 112 108 +3% 305 334 -8%
Earth Data 69 136 -49% 200 306 -35%
SMO 56 69 -18% 178 249 -28%
Land 26 24 +11% 76 119 -37%
Marine 14 21 -32% 49 67 -26%
Other 16 24 -34% 53 62 -15%
Segment EBITDAs 100 167 -40% 260 417 -38%
Adjusted Segment EBITDAs 100 167 -40% 268 417 -36%
DDE 112 170 -34% 302 408 -26%
SMO -5 4 n.a. -12 30 n.a.
Corporate and other -6 -7 -15% -22 -22 +1%
Segment Operating Income 19 93 -79% 27 179 -85%
Adjusted Segment Operating Income 19 93 -79% 36 179 -80%
DDE 38 103 -63% 91 190 -52%
SMO -11 -2 +421% -29 13 n.a.
Corporate and other -8 -8 -8% -26 -24 +7%
EDA Cash EBITDA 19 73 -74% 47 112 -58%

Other KPIs

(in millions of $) Q3 2026 Q3 2025 Change (%) 9M 2026 9M 2025 Change (%)
Geoscience backlog 267 290 -8% 267 290 -8%
Total capex 47 54 -12% 138 173 -20%
Earth Data library net book value 345 534 -35% 345 534 -35%

Definition of Alternative Performance Indicators (API)

In its communications, Viridien includes Alternative Performance Indicators, the main ones being Segment Revenue, Segment EBITDAs, Adjusted Segment EBITDAs, and EDA Cash EBITDA. Their definitions are set out in the 2025 Universal Registration Document filed with the French Financial Markets Authority (AMF) and are reiterated below:

  • Segment Revenue: Segment Revenue is prepared in accordance with internal management reporting with Earth Data prefunding revenues recorded based upon percentage of completion.
  • Segment EBITDAs: Segment EBITDAs is defined as earnings before interest, tax, income from equity affiliates, depreciation, amortization net of amortization costs capitalized to Earth Data surveys, and cost of share-based compensation for employees and senior executives. The cost of share-based compensation includes the cost of stock options and allotments of performance shares. Segment EBITDAs is calculated based on internal management reporting, in which prefunding revenue from Earth Data surveys is recognized using the percentage of completion method.
  • Adjusted Segment EBITDAs: Adjusted Segment EBITDAs is Segment EBITDAs adjusted for non-recurring charges and gains.
  • EDA Cash EBITDA: EDA Cash EBITDA is defined as EDA (Earth Data) Adjusted Segment EBITDAs less investment in EDA surveys for the period, excluding inactivity compensation fees related to the vessel capacity agreement signed between Viridien and Shearwater. This indicator is used exclusively for the EDA activity.

Reconciliation of API with the consolidated financial statements

The table below outlines the accounting adjustments made in accordance with IFRS 158 requirements. Over the period, these adjustments primarily relate to major survey projects conducted by Earth Data in the US Gulf, Norway and Guyana.

(in millions of $) Q3 2026 9M 2026
Segment IFRS 15 adjustments IFRS Segment IFRS 15 adjustments IFRS
Revenue 237 -2 236 683 88 771
EBITDAs 100 -2 98 260 88 348
Non-recurring charges and gains 0   0 9   9
Adjusted EBITDAs 100 -2 98 268 88 356
Operating Income 19 -7 13 27 -2 25
Non-recurring charges and gains 0   0 9   9
Adjusted Operating Income 19 -7 13 36 -2 34

Interim Consolidated Statement of Operations

(in millions of $, except per share data) 9M 2026 9M 2025
Operating revenues 771.3 758.1
Other income from ordinary activities 0.3 0.2
Total income from ordinary activities 771.6 758.2
Cost of operations (646.8) (520.8)
Gross profit 124.8 237.4
Research and development expenses – net (8.1) (9.1)
Marketing and selling expenses (25.0) (25.6)
General and administrative expenses (57.7) (54.9)
Other revenues (expenses) – net (8.7) 0.9
Operating Income (loss) 25.3 148.7
Cost of financial debt – gross (75.0) (83.5)
Income from cash and cash equivalents 3.1 4.0
Cost of financial debt – net (71.9) (79.5)
Other financial income (loss) (0.8) (34.9)
Income (loss) before income taxes and share of income (loss) from companies accounted for under the equity method (47.3) 34.3
Income taxes 0.4 (16.3)
Income (loss) before share of income (loss) from companies accounted for under the equity method (47.0) 18.0
Net income (loss) from companies accounted for under the equity method (0.0) (1.1)
Net income (loss) from continuing operations (47.0) 16.8
Net income (loss) from discontinued operations 1.1 2.5
Consolidated net income (loss) (45.9) 19.3
Attributable to:    
Owners of Viridien SA (47.2) 18.5
Non-controlling interests 1.4 0.8
     
Weighted average number of ordinary shares outstanding (a) 7,202,446 7,169,701
Weighted average number of shares outstanding adjusted for dilutive potential ordinary shares (b) 7,202,446 7,217,141
Net income (loss) per share    
Basic (a) (6.56) 2.59
Diluted (b) (6.56) 2.57
Net income (loss) from continuing operations per share    
Basic (a) (6.71) 2.23
Diluted (b) (6.71) 2.22
Net income (loss) from discontinued operations per share    
Basic (a) 0.16 0.35
Diluted (b) 0.16 0.35

Interim Consolidated Statement of Financial Position

(in millions of $) Sep. 30, 2026 Dec. 31, 2025
ASSETS    
Cash and cash equivalents 204.8 173.0
Trade accounts and notes receivable, net 247.1 315.0
Inventories and work-in-progress, net 171.8 164.3
Income tax assets 25.8 31.7
Other current assets, net 78.6 74.9
Assets held for sale, net 15.8 15.8
Total current assets 743.8 774.7
Deferred tax assets 52.9 43.4
Other non-current assets, net 10.0 10.0
Investments and other financial assets, net 30.8 30.3
Investments in companies accounted for under the equity method 0.1 0.1
Property, plant and equipment, net 245.0 227.4
Intangible assets, net 421.2 571.9
Goodwill, net 1,089.9 1,092.2
Total non-current assets 1,850.1 1,975.3
TOTAL ASSETS 2,593.8 2,750.0
     
LIABILITIES AND EQUITY    
Financial debt – current portion 89.2 56.2
Trade accounts and notes payables 84.5 66.5
Accrued payroll costs 92.7 97.5
Income taxes payable 8.9 22.3
Advance billings to customers 22.8 17.9
Provisions – current portion 7.0 14.4
Other current financial liabilities 0.0 0.0
Other current liabilities 150.9 256.7
Liabilities associated with non-current assets held for sale 1.0 1.0
Total current liabilities 457.0 532.6
Deferred tax liabilities 5.3 9.1
Provisions – non-current portion 34.2 33.3
Financial debt – non-current portion 956.3 1,004.8
Other non-current financial liabilities 0.0 0.0
Other non-current liabilities 0.9 2.0
Total non-current liabilities 996.7 1,049.2
Common stock: 10,834,394 shares authorized and 7,219,747 shares
with a nominal value of €1.00 outstanding at September 30, 2026
8.8 8.8
Additional paid-in capital 120.1 119.1
Retained earnings 1,066.4 1,110.2
Treasury shares (20.1) (20.1)
Cumulative income and expense recognized directly in equity (0.7) (1.4)
Cumulative translation adjustment (74.5) (86.2)
Equity attributable to owners of Viridien S.A. 1,099.9 1,130.4
Non-controlling interests 40.2 37.8
Total equity 1,140.2 1,168.3
TOTAL LIABILITIES AND EQUITY 2,593.8 2,750.0

Interim Consolidated Statement of Cash Flows

(in millions of $)   9M 2026 9M 2025
OPERATING ACTIVITIES      
Consolidated net income (loss)   (45.9) 19.3
Less: Net income (loss) from discontinued operations   (1.1) (2.5)
Net income (loss) from continuing operations   (47.0) 16.8
Depreciation, amortization, and impairment   62.6 64.3
Impairment and amortization of Earth Data surveys   267.4 83.2
Amortization and depreciation of Earth Data surveys, capitalized   (13.7) (12.1)
Variance on provisions   (5.4) (5.5)
Share-based compensation expenses   4.0 3.3
Net (gain) loss on disposal of fixed and financial assets   9.8 (1.3)
Share of (income) loss in companies recognized under equity method   0.0 1.1
Other non-cash items   1.4 30.3
Net cash-flow including net cost of financial debt and income tax   279.2 180.2
Less: Cost of financial debt   71.9 79.5
Less: Income tax expense (gain)   (0.4) 16.3
Net cash-flow excluding net cost of financial debt and income tax   350.7 276.0
Income tax paid, net   (12.2) (14.0)
Net cash-flow before changes in working capital   338.5 261.9
Changes in working capital   (58.9) 58.1
– change in trade accounts and notes receivable   (31.5) 122.5
– change in inventories and work-in-progress   (12.6) 16.7
– change in other current assets   (11.0) (2.4)
– change in trade accounts and notes payable   14.8 (64.9)
– change in other current liabilities   (18.6) (13.7)
Net cash-flow from operating activities    279.6 320.1
       
INVESTING ACTIVITIES      
Total capital expenditures (tangible and intangible assets) net of variation of fixed assets suppliers and excluding Earth Data surveys   (35.1) (26.7)
Investment in Earth Data surveys   (103.0) (146.0)
Proceeds from disposals of tangible and intangible assets   2.4 1.0
Proceeds from divestment of activities and sale of financial assets   1.4 1.0
Variation in other non-current financial assets   5.4 4.1
Net cash-flow from investing activities   (129.0) (166.6)

FINANCING ACTIVITIES      
Repayment of long-term debt   (44.2) (1,075.8)
Total issuance of long-term debt   11.7 955.6
Call premium   (1.2) (21.9)
Refinancing transaction costs paid   0.0 (3.7)
Lease repayments   (41.2) (44.1)
Financial expenses paid   (40.2) (41.4)
Net proceeds from capital increase:      
– from shareholders   0.9 0.0
– from non-controlling interests of integrated companies   0.0 0.0
Dividends paid and share capital reimbursements:      
– to shareholders   0.0 0.0
– to non-controlling interests of integrated companies   (0.7) (1.4)
Net cash-flow from financing activities   (114.8) (232.8)
       
Effects of exchange rates on cash   0.1 4.4
Impact of changes in consolidation scope   (3.7) 0.0
Net cash flows incurred by discontinued operations   (0.4) (0.2)
Net increase (decrease) in cash and cash equivalents   31.8 (75.1)
Cash and cash equivalents at beginning of year   173.0 301.7
Cash and cash equivalents at end of period   204.8 226.6


1 Quarterly statements are unaudited and not subject to any review
2 The net debt calculation has been revised to exclude accrued interest, thereby aligning Viridien’s methodology with its banking documentation
3 Please refer to the “Definitions of Alternative Performance Indicators” in the appendices for explanations of the terms used in this section
4 The reconciliation of alternative performance indicators to the consolidated financial statements is provided in the appendices, along with their definitions
5 $125m RCF of which $25m ancillary guarantee facility (virtually fully utilized) and $100m fully undrawn

6 Including a $17m positive foreign exchange impact compared to December 31, 2025. Net of capitalized refinancing fees
7 The Net Debt calculation has been revised to exclude accrued interest, thereby aligning Viridien’s methodology with its banking documentation

8 IFRS 15 requires that Earth Data prefunding revenues be recognized only upon delivery of the final processed data, that is, when the performance obligation is fulfilled. As a result, revenue and margin recognition for ongoing surveys is deferred. Viridien’s segment reporting, however, continues to apply the percentage-of-completion method previously used before the adoption of IFRS 15, for recognizing Earth Data prefunding revenues and associated margins

Attachment

Disclosure Of Trading In Own Shares
For October 2026

Clichy, France – November 03, 2026

In compliance with general regulation on share buy-backs, Société BIC declares below the transactions made on its own shares for October 2026:

Date Number of shares Average weighted price in € Amount in €
01/10/2026 10,193 64.8795 661,316.80
01/10/2026 14,382 65.0000 934,830.00
05/10/2026 2,269 64.9769 147,432.60
07/10/2026 140 64.9000 9,086.00
08/10/2026 7,675 65.3000 501,177.50
13/10/2026 25,628 65.8000 1,686,322.40
13/10/2026 2,466 65.7837 162,222.60
TOTAL 62,753 65.3736 4,102,387.91

Contacts

Investor Relations
investors.info@bicworld.com

Brice Paris
VP Investor Relations
+33 6 42 87 54 73
brice.paris@bicworld.com

Apolline Celeyron
Global Communications Director
+33 6 13 63 44 43 apolline.celeyron@bicworld.com

Isabelle de Segonzac
Image 7, Press Relations contact
+33 6 89 87 61 39
isegonzac@image7.fr
 

Agenda

All dates to be confirmed

Full Year 2026 Results February 24, 2027
First Quarter 2027 Net Sales April 28, 2027

About BIC

A global leader in stationery, lighters, shavers and hairbrushes, BIC brings simplicity and joy to everyday life. For 80 years, BIC’s commitment to delivering high-quality, affordable, and trusted products has established BIC as a symbol of reliability and innovation. With a presence in over 160 countries, and over 11,000 team members worldwide, BIC’s portfolio includes iconic brands and products such as BIC® 4-Color™, Cristal®, BIC Kids®, Lucky™, Tipp-Ex®, Wite-Out®, Djeep®, EZ Load™, EZ Reach®, BIC® Flex™, Soleil®, Tangle Teezer® and more. Listed on Euronext Paris and included in the SBF120 and CAC Mid 60 indexes, BIC is also recognized for its commitments to sustainability and education. For more, visit www.corporate.bic.com. Follow BIC on LinkedIn, Instagram, YouTube and TikTok.

Attachment

03/11/2026

LACROIX GROUP: SHARE BUYBACK PROGRAM

In accordance with Articles 241-1 and 242-2 of the regulations of the Autorité des Marchés Financiers, this document describes the share buyback program authorized by the Shareholders’ Meeting of May 13, 2026, the implementation of which was decided by the Board of Directors.

1. Date of the general meeting of shareholders that authorized the buyback program

The Company’s authorization to buy back its own shares was given by the Ordinary General Meeting of May 13, 2026 (13th resolution). It is implemented within the framework of this plan by decision of the Board of Directors dated October 29, 2026.

2. Breakdown by objectives of equity securities held to date

To date, the company holds 107 443 of its own shares, representing 2,23% of the capital, the breakdown by objective of which is as follows:

Retired shares 0 share
Delivery of shares on the exercise of securities giving access to the share capital 0 share
Coverage of stock option plans or plans for the allocation of free shares to employees and corporate officers 45 838 shares
Liquidity contract 6 271 shares
Surrender of shares in the context of external growth operations 55 334 shares

3. Objectives of the buyback program

The share buyback objectives are to:

– To ensure the animation of the security through a liquidity contract in accordance with the practice allowed by the regulations in force;

– To purchase shares with a view to their retention and subsequent delivery on exchange or in payment as part of external growth operations, it is specified that the shares acquired for this purpose may not exceed 5% of the Company’s share capital and that the Company may not directly or indirectly hold more than 10% of its share capital;

– To ensure the coverage of free share allocation plans or stock options and, more generally, of all share ownership plans for employees and agents of the Group;

– To ensure the hedging of securities entitling to the allocation of shares of the Company within the framework of the regulations in force.

This buyback program would also be intended to allow the Company to operate for any other purpose authorized or that may be authorized by law or regulations in force, to implement any market practice that may be accepted by the Autorité des Marchés Financiers. In such a case, the Company would inform its shareholders by means of a press release.

4. Maximum share capital, maximum number of securities, characteristics of the securities to be acquired, maximum purchase price and other terms and conditions

In compliance with the limits voted in the 13th resolution of the Ordinary General Meeting of May 13, 2026, the share buyback program will be implemented under the following conditions:

The maximum number of shares that may be purchased is set at 482,909 (i.e. 10% of the share capital). The Shareholders’ Meeting decides that the maximum purchase price per share may not exceed €60. In the event of a share capital transaction, in particular a share split or consolidation or a free allocation of shares, the above-mentioned amount will be adjusted in the same proportions (multiplier equal to the ratio between the number of shares making up the share capital before the transaction and the number of shares after the transaction).

The maximum overall amount of the operation is thus set at €28,974,540.

The shares will be purchased by market intervention or by block trades of securities within the framework of applicable legal and regulatory provisions. Block acquisitions may reach the entire program.

The number of shares held pursuant to this authorization may not exceed 10% of the share capital, i.e. 482,909 shares, adjusted if necessary to consider any capital increase operations that may occur during the duration of the program.

– The Company’s shares are ordinary shares, all the same class, listed on the Euronext Paris market (ISIN FR0000066607);
– The buybacks will be carried out by an independent investment services provider which will be entrusted with the task of implementing the share buyback program, on behalf of and for the benefit of the Company’s account, depending on market conditions and taking care not to disrupt the latter.

5. Duration of the program

18 months from May 13, 2026, in accordance with the authorization given at the Ordinary General Meeting of the same day, i.e. no later than November 13, 2027 included.

Next financial release

FY 2026 revenue: 9 February 2027, after market close

All financial information is available in our Investors section

https://www.lacroix-group.com/investors

About LACROIX

LACROIX is a French mid-cap technology and industrial group with an international footprint, specializing in the design and manufacture of electronic equipment, as well as the delivery of reliable and secure industrial IoT solutions.   
A family-owned, publicly listed company, LACROIX generated €445 million in revenue in 2025. The Group builds on recognized expertise and structures its development around two core business activities: Electronics and Environment.   

Through its Electronics activity, LACROIX supports its customers from design to the manufacturing of embedded electronics for their solutions. Leveraging a network of geographically complementary and competitive manufacturing sites, the Group serves a wide range of sectors, including automotive, industry, connected Homes and Buildings (HBAS), Aerospace and Defense, and Healthcare.   

Through its Environment activity, LACROIX supports public and private stakeholders in optimizing and securing the management of critical infrastructure networks by offering connected and secure solutions and services dedicated to Water networks, Heating, Ventilation and Air Conditioning (HVAC) systems, Energy networks (Smart Grids), and Public Lighting.   

LACROIX pursues a strategy of sustainable long-term growth. The Group focuses its activities on the development of useful and eco-designed technologies aimed at addressing major societal challenges, as part of a resilience-driven approach with a positive impact.   

  

Attachment

NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) — Teamshares (Nasdaq:TMS), a tech-enabled acquiror of SMEs, announced today that Mike Levin has joined the Company as Senior Director of Investor Relations. Mike Levin is a CFA charterholder that brings significant experience in public company investor relations and equity research, including helping build the investor relations function at Carvana following an equity research role at Deutsche Bank. He will report to Nile Corso, Head of Capital Markets, and will focus on expanding Teamshares’ institutional investor relationships and shareholder engagement.

“Mike’s experience in investor relations and equity research will be valuable as we build our IR function and expand our engagement with institutional investors. We look forward to working with Mike to broaden awareness and understanding of Teamshares among public market investors,” said Nile Corso, CFA.

About Teamshares
Teamshares is a tech-enabled acquiror of high-quality businesses, intending to be a permanent home for businesses. Part holdco, part fintech, Teamshares programmatically acquires companies with $0.5 to $5 million of EBITDA from retiring owners, integrates them with the Teamshares platform, and helps employees earn operating company stock. Founded in 2019, Teamshares operates subsidiaries with consolidated revenue of over $500 million for the trailing twelve month period as of June 30, 2026 across over 40 industries and 30 states. Learn more at https://investors.teamshares.com/

Contacts
Investor Relations: Investors@teamshares.com
Press: Press@teamshares.com

HONG KONG, Nov. 03, 2026 (GLOBE NEWSWIRE) — PS International Group Ltd. (NASDAQ: PSIG) (“PSIG” or the “Company”), a long-established global logistics service provider headquartered in Hong Kong specializes in cross-border air freight services, today announced its unaudited financial results for the six months ended June 30, 2026.

Financial Summary for the Six Months Ended June 30, 2026

  • Revenues were $26.5 million, an increase of 14.4%.
  • Gross profit was $0.1 million, a decrease of 38.8%.
  • Net loss was $10.1 million, compared to a net loss of $0.4 million in the prior period.

Key Components of Our Results of Operations

The following table sets forth a summary of our unaudited consolidated results of operations for the six months ended June 30, 2025 and 2026. This information should be read together with our consolidated financial statements and related notes included elsewhere in this document.

  For the Six Months
Ended June 30,
  2025 2026
  US$ US$
Revenues 23,124,641   25,100,878  
Revenues – Related Party 63,159   1,432,713  
Total Revenues 23,187,800   26,533,591  
     
Cost of Revenue 22,476,099   26,184,117  
Cost of Revenue – Related Party 499,718   219,713  
Total Cost of Revenue 22,975,817   26,403,830  
     
Gross Profit 211,983   129,761  
     
General and administrative expenses 2,159,899   1,353,046  
Total operating expenses 2,159,899   1,353,046  
     
Loss from Operations (1,947,916 ) (1,223,285 )
     
Other Income (Loss):    
Interest income 20,878   60,227  
Interest expense —   (233,728 )
Change in fair value of warrant liabilities —   (11,811,648 )
Gains on settlement of warrant liabilities —   628,406  
Net gains on marketable equity securities —   2,512,725  
Other income 1,468,587   12  
Exchange gain (loss) 43,253   (4,556 )
Total other income (loss) 1,532,718   (8,848,562 )
     
Loss Before Income Tax (415,198 ) (10,071,847 )
Income Tax —   —  
Net Loss (415,198 ) (10,071,847 )
         
Net loss attributable to PS International Group Ltd. (416,808 ) (10,064,745 )
         
Weighted average ordinary shares outstanding – basic and diluted 3,247,117   14,145,276  
Net loss per ordinary share – basic and diluted (0.13 ) (0.71 )
         

Revenues

We generate revenues primarily from the provision of air and ocean export and import freight forwarding services during the six months ended June 30, 2025 and 2026. The table below sets forth the breakdown of our revenues by service type for the periods indicated.

  For the Six Months
Ended June 30,
  2025 2026
  US$ US$
Freight forwarding services    
– Air freight 22,552,413 26,295,812
– Ocean freight 599,588 236,003
Subtotal 23,152,001 26,531,815
Ancillary logistic services 35,799 1,776
Total 23,187,800 26,533,591
     

Freight forwarding services

The Company derives revenues primarily from our freight forwarding services include arranging for consignment upon receipt of booking instructions from customers, cargo pick up, obtaining cargo space, preparation of freight documentation, arranging for customs clearance and cargo handling at origin and destination as well as other related logistics services such as supporting transportation for freight forwarding purposes, by purchasing transportation services from direct (asset-based) carriers or other freight forwarders and reselling those services to its customers. For the six months ended June 30, 2025 and 2026, our revenues from air freight forwarding were US$22.6 million and US$26.3 million, respectively, representing 97.2% and 99.1% of our total revenue for the same period.

Ancillary logistics services

Our ancillary logistics services involve the provision of a wide range of logistics services, such as cargo pickup, cargo handling at ports and local transportation, and warehousing related services, such as repackaging, labelling, palletization, preparation of shipping documentation, arrangement of customs clearance and warehousing.

Revenue from freight forwarding services is mainly derived from export shipments. The following table sets forth the breakdown of revenue from freight forwarding services for the six months ended June 30, 2025 and 2026.

  For the Six Months
Ended June 30,
  2025 2026
  US$ US$
Export shipments    
– Air 22,551,083 26,295,812
– Ocean 598,148 234,420
– Subtotal 23,149,231 26,530,232
     
Import shipments    
– Air 1,330 —
– Ocean 1,440 1,583
– Subtotal 2,770 1,583
Total 23,152,001 26,531,815
     

For the six months ended June 30, 2025 and 2026, we focused on export freight forwarding services, which contributed to US$23.2 million and US$26.5 million, respectively, representing substantially all (99.9%) of our revenue from freight forwarding services during the same period.

For the six months ended June 30, 2025 and 2026, our revenue was principally derived from the provision of air and ocean export freight forwarding services. The table below sets forth the breakdown of export revenue by destination for the periods indicated.

  For the Six Months
Ended June 30,
  2025 2026
  US$, except percentages
United States 16,447,419 71.05 % 15,093,633 56.89 %
Canada 935,807 4.04 % 213,254 0.80 %
France 60,860 0.26 % 20,232 0.08 %
United Kingdom 1,558,376 6.73 % 1,512,267 5.70 %
The Netherlands 1,618,362 7.00 % 926,938 3.49 %
Mexico 6,652 0.03 % 7,110,033 26.80 %
Others (Note) 2,521,755 10.89 % 1,653,875 6.24 %
Total export revenue 23,149,231 100 % 26,530,232 100 %
             

Note: Others represent a number of countries including, among others, Qatar, Japan, Malaysia and Cyprus, etc.

For the six months ended June 30, 2025 and 2026, our revenue from freight and ocean forwarding services for export shipments to the United States contributed to US$16.4 million and US$15.1 million, respectively, representing 71.0% and 56.9% of our total export revenue during the same period. Export revenue to Mexico increased from US$6,652 for the six months ended June 30, 2025 to US$7,110,033 for the six months ended June 30, 2026, representing 0.03% and 26.8% of our total export revenue, respectively.

The following table sets forth the breakdown of our revenue by type of customers for the six months ended June 30, 2025 and 2026:

  For the Six Months
Ended June 30,
  2025 2026
  US$ US$
Freight forwarders 23,040,700 21,961,910
Direct customers 147,100 4,571,681
Total 23,187,800 26,533,591
     

We focus on provision of freight forwarding services to freight forwarders, which generated revenue of US$23.0 million and US$22.0 million for the six months ended June 30, 2025 and 2026, respectively, representing 99.4% and 82.8% of our total revenue for the same period. Revenue from direct customers increased from US$0.1 million for the six months ended June 30, 2025 to US$4.6 million for the six months ended June 30, 2026, representing 17.2% of our total revenue for the six months ended June 30, 2026.

Cost of Revenue

Our cost of revenue amounted to US$23.0 million and US$26.4 million for the six months ended June 30, 2025 and 2026, respectively, representing 99.1% and 99.5% of our total revenue for the same periods.

Our cost of revenue mainly comprised of air and ocean freight charges, and warehouse and transportation cost. Air and ocean freight charges represented costs of cargo space charged by airlines, shipping liners or other freight forwarders. Air freight charges were the major component of our cost of revenue.

Logistics and warehousing fees primarily represent costs and service fees incurred in relation to warehousing services such as x-ray screening, storage, palletizing and consolidation performed in our warehouse and costs of local trucking and transportation services.

Gross profit

Our total gross profit amounted to US$0.2 million and US$0.1 million for the six months ended June 30, 2025 and 2026, respectively. We recorded overall gross profit margin of 0.9% and 0.5% for the same period. Our gross profit and gross profit margin are mainly affected by the spread we earn between the freight charge per kilogram payable by our customers and the freight charges payable to suppliers we are able to secure. The gross profit margin dropped came from failing to pass through rising buy-side rates in a price-competitive co-load/direct-customer mix, while the HK export lane itself shrank.

General and administrative expenses

Our general and administrative expenses decreased from US$2.2 million for the six months ended June 30, 2025 to US$1.4 million for the six months ended June 30, 2026, primarily driven by the decrease in staff costs and benefits, which was mainly attributable to the recognition of a share-based compensation benefit of US$77,704 in the first six months of 2026, compared with share-based compensation expenses of US$663,202 recognized in the first six months of 2025.

Other income

Our other income decreased from US$1.5 million for the six months ended June 30, 2025 to approximately nil for the six months ended June 30, 2026. The prior period benefited from the reversal of provisions for staff injury compensation of US$328,615 and for a supplier’s penalty claim of US$1,130,242 upon settlement of the related claims, whereas only miscellaneous income of US$12 was recognized in the six months ended June 30, 2026.

Interest income

Our interest income increased from US$20,878 for the six months ended June 30, 2025 to US$60,227 for the six months ended June 30, 2026, primarily due to interest income of US$60,000 recognized on the loan receivable of US$2,000,000 granted to an independent third party in December 2025.

Interest expense

For the six months ended June 30, 2026, we incurred interest expense of US$233,728, comprising US$59,542 on a secured bank loan and US$174,186 on other secured borrowings, whereas no interest expense was incurred for the six months ended June 30, 2025.

Change in fair value of warrant liabilities and gains on settlement

In connection with the cashless exercise of all outstanding Warrants on February 3, 2026, we recorded a loss of US$11.8 million from the change in fair value of warrant liabilities during the six months ended June 30, 2026, partially offset by a gain of US$628,406 on the settlement of the warrant liabilities. No such items were recorded in the six months ended June 30, 2025.

Net gains on marketable equity securities

For the six months ended June 30, 2026, we recorded net gains on marketable equity securities of US$2.5 million, consisting of unrealized gains of US$2,475,010 and a realized gain of US$37,715 on the disposal of 29,000 shares of XMax Inc. No such gains were recorded in the six months ended June 30, 2025.

Exchange gain

Our exchange gain decreased from US$43,253 for the six months ended June 30, 2025 to an exchange loss of US$4,556 for the six months ended June 30, 2026, which was primarily driven by fluctuation of RMB and US$ against HKD.

Income tax

Our income tax expense for the six months ended June 30, 2025 and for the six months ended June 30, 2026, respectively, were Nil as a result of taxable loss incurred for both periods.

Net loss

As a result of the above factors, our net loss for the six months ended June 30, 2025 and for the six months ended June 30, 2026 were US$0.4 million and US$10.1 million, respectively. Net loss attributable to PS International Group Ltd. was US$0.4 million and US$10.1 million for the respective periods. Our net loss margin changed from -1.8% for the six months ended June 30, 2025 to -38.0% for the six months ended June 30, 2026.

Cash flows

The table below sets forth a summary of our cash flows for the six months ended June 30, 2025 and 2026:

  For the Six Months
Ended June 30,
  2025 2026
  US$ US$
Net cash (used in) operating activities (817,584 ) (3,173,760 )
Net cash (used in) investing activities (1,014,208 ) (36,935 )
Net cash (used in) financing activities —   (565,175 )
Net (decrease) in cash and cash equivalents and restricted cash (1,831,792 ) (3,775,870 )
         

Cash used in operating activities

Our operating cash inflow is primarily from our operating activities principally from the receipt of payments for our provision of freight forwarding services, whereas our outflow from operating activities is principally for freight charges, ancillary service fees payable to suppliers, payment of salaries and employee benefits and general and administrative expenses.

For the six months ended June 30, 2025, our net cash used in operating activities was US$0.8 million, mainly attributable to (i) our net loss of US$0.4 million which was primarily adjusted for operating lease expenses of US$51,352, share-based compensation expenses of US$663,202 and reversal of provision for compensation and penalty of US$1.4 million; (ii) decrease in accounts payables to third party of US$7.3 million; (iii) decrease in other payables and accrued liabilities of US$0.2 million; and (iv) decrease in provision for penalty of US$0.1 million; which was partially offset by (v) decrease in accounts receivables of US$7.5 million and (vi) decrease in contract assets of US$0.7 million.

For the six months ended June 30, 2026, our net cash used in operating activities was US$3.2 million, mainly attributable to (i) our net loss of US$10.1 million, which was primarily adjusted for the change in fair value of warrant liabilities of US$11.8 million, depreciation of property, plant and equipment of US$109,014 and operating lease expenses of US$44,104, and partially offset by net gains on marketable equity securities of US$2.5 million, gains on settlement of warrant liabilities of US$0.6 million and a share-based compensation benefit of US$77,704; (ii) decrease in accounts payable of US$3.6 million and decrease in other payables and accrued liabilities of US$0.3 million; which was partially offset by (iii) decrease in accounts receivable of US$1.0 million, settlement of the amount due from a related party of US$0.9 million and decrease in accounts receivable from a related party of US$0.4 million.

Cash used in investing activities

Our net cash used in investing activities primarily relates to the purchase of property, plant and equipment and loans granted, partially offset by proceeds from the disposal of marketable equity securities.

For the six months ended June 30, 2025, our net cash used in investing activity of purchasing the office premises and motor vehicle parking spaces was US$1 million.

For the six months ended June 30, 2026, our net cash used in investing activities was US$36,935, primarily comprising proceeds from the disposal of marketable equity securities of US$211,635, partially offset by the purchase of property, plant and equipment of US$165,494 and a loan granted of US$83,076.

Cash used in financing activities

For the six months ended June 30, 2025, there was no financing activity.

For the six months ended June 30, 2026, our net cash used in financing activities was US$565,175, representing the repayment of borrowings.

Recent Development

(a) Cashless Exercise of Warrants

On February 3, 2026, in connection with the Private Placement completed on November 12, 2025, the Company issued 6,753,470 ordinary shares to the Purchasers in exchange for all of the Warrants then outstanding, pursuant to the alternate cashless exercise provision of the warrant agreement. As a result, the warrant liabilities with a carrying amount of US$34.2 million were derecognized, the ordinary shares issued were recorded at an aggregate amount of US$33.6 million, and a gain on settlement of the warrant liabilities of US$628,406 was recognized. No Warrants were outstanding as of June 30, 2026.

(b) Shelf Registration Statement on Form F-3

On August 4, 2026, the Company filed a registration statement on Form F-3 (File No. 333-297955) with the U.S. Securities and Exchange Commission (the “SEC”) using a shelf registration process, and the registration statement was declared effective by the SEC on August 19, 2026. Under the shelf registration statement, the Company may, from time to time, offer and sell, in one or more offerings, up to an aggregate initial offering price of US$200,000,000 of ordinary shares, warrants to purchase ordinary shares, debt securities, rights and units (or any combination thereof), at prices and on terms to be determined at the time of sale and described in one or more prospectus supplements. As of the date of this press release, no securities had been offered or sold under the shelf registration statement.

About PS International Group Ltd.

PSIG is a long-established global logistics and supply chain solution provider specializing in air freight forwarding, ocean freight forwarding and end-to-end supply chain ancillary services, connecting Asian transportation hubs with the United States and over 140 other global markets. The Company operates its core businesses through two Hong Kong-based operating subsidiaries: Profit Sail Int’l Express (H.K.) Limited and Business Great Global Supply Chain Limited. Additional corporate and operational information is available on the Company’s official website: https://www.psi-groups.com/.

Forward-Looking / Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the Company’s expectations, beliefs, plans, objectives, prospects and future financial or operating performance, and future capital market and operational strategies. These statements use identifying terminology such as “intend,” “will,” “plan,” “may,” “anticipate,” “evaluate,” “potential” and similar phrasing.

All forward-looking statements rely on management’s current expectations, forecasts and assumptions, and carry inherent known and unknown risks, uncertainties and external variables that could cause actual outcomes to differ materially from projected results. Key risks include volatile share price performance, fluctuations in the Company’s market capitalization, challenging global logistics market conditions, and unforeseen regulatory or capital market barriers. The Company undertakes no public obligation to update, amend or revise any forward-looking statements to reflect post-release events, new information or changed business circumstances, unless mandatory under applicable U.S. federal securities laws. Investors should carefully review all risk disclosures and operational details contained in the Company’s SEC filings, including its annual Form 20-F and periodic Form 6-K reports, which are available for review at www.sec.gov.

For more information, please contact:

PS International Group Ltd.

Joseph Chan

Chief Financial Officer

Email: joseph.chan@psi-groups.com; Tel: (852) 2754 3320

The free, community-sourced cookbook features Vibha Ajwani of Scarborough and Harinder Dhaliwal of Kitchener-Waterloo, and the family dishes at the heart of their Diwali celebrations

Vibha

Vibha Ajwani - Kesar Shrikhand
Vibha Ajwani – Kesar Shrikhand

Harinder

Harinder Dhaliwa - Aloo Parantha
Harinder Dhaliwa – Aloo Parantha

TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) — This Diwali, Food Basics is sharing some of Ontario’s most cherished family recipes with the first edition of More Flavours of Home, a free, community-sourced cookbook series that celebrates the residents and families who keep cultural traditions alive through food. 

For many communities across Ontario, Diwali is a cherished annual celebration, with food and family recipes often at the heart of the festivities. For many, preserving these recipes is an important way of passing culture between generations. In a 2024 survey by the Canadian Health Food Association, 78 per cent of BIPOC Canadians said they want to learn traditional cooking techniques to pass them on to future generations. 

Following nominations from across the province, Vibha Ajwani of Scarborough and Harinder Dhaliwal of Kitchener-Waterloo were selected to share their recipes, traditions and stories in the cookbook, told in their own words and photos.

In Vibha’s kitchen, there’s always a festival on the horizon. A home cook who blends traditional and modern Indian cooking, she sees every recipe as a way to keep her family’s traditions alive and pass them from one generation to the next. For this edition, she’s contributing her Kesar Shrikhand, a saffron and cardamom yogurt dessert that has a special place at her family’s Diwali celebrations.

“Each of our festivals, from Holi to Ganesh Chaturthi to Diwali, has its own special traditions and dishes,” said Vibha. “I love preparing these foods for my family because they connect me to the generations before me and allow me to keep our culture and traditions alive for generations to come. Having one of my recipes featured in a cookbook makes me incredibly proud of my cooking and my heritage.”

Harinder is a familiar face in Kitchener-Waterloo’s South Asian community, and her volunteer work with House of Friendship have earned community recognition. Her contribution to More Flavours of Home is her Aloo Parantha, a flatbread stuffed with spiced potatoes that brings her family together at Diwali and all year round.

“This recipe is one my family has been enjoying for generations and it’s so important to me to continue passing these dishes and flavours on,” said Harinder. “Being part of this cookbook means sharing some of our joy with all of Ontario and maybe starting a new tradition in someone else’s kitchen celebrating beautiful moments with their families for all holiday gatherings.”

“Many of the recipes that live in kitchens like Vibha’s and Harinder’s aren’t written down. Instead, they are learned at a family member’s side and measured by a handful of this and a pinch of that, they’ve been carried across oceans and kept alive in Ontario kitchens for generations,” said Hardeep Kharaud, SVP, Food Basics. “More Flavours of Home is our way of honouring the people who keep these traditions alive and helping more Ontarians bring them to their own tables this Diwali.”

More Flavours of Home builds on More Flavours of the World, the platform Food Basics launched earlier this year to spotlight the thousands of international products on its shelves. The Diwali edition is available free at foodbasics.ca/more-flavours, and every ingredient needed to recreate Vibha’s and Harinder’s dishes can be found in-store and online through Food Basics across Ontario. New editions celebrating Lunar New Year and Ramadan will follow in early 2027.

About Food Basics
Since 1995, Food Basics has been helping customers save money on their grocery needs by providing Always More for Less. Food Basics operates on three guiding principles: Always Fresh, Always in Stock and Always at Great Prices. Food Basics is the discount banner of Metro Ontario Inc. and currently operates 160 stores across Ontario.

About METRO Inc.
With annual sales of more than $22 billion, METRO Inc. is a food and pharmacy leader in Québec and Ontario, providing employment to more than 97,000 people. Its purpose is to Nourish the health and well-being of our communities. As a retailer, franchisor, distributor, manufacturer, and provider of eCommerce services, the company operates or services a network of some 1,000 food stores under several banners including Metro, Metro Plus, Super C, Food Basics, Adonis and Première Moisson, and some 640 pharmacies primarily under the Jean Coutu, Brunet, Metro Pharmacy and Food Basics Pharmacy banners. For more details, visit corpo.metro.ca and follow the latest news on LinkedIn.

Attachments

CONTACT: Lara Cruz
Metro Inc.
647-804-2056
lcruz@thinkagnostic.com

NEWARK, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL) today announced that it will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on Monday, November 9, 2026 at 3:55 p.m. ET, and host one-on-one meetings with institutional investors.

A live webcast can be accessed with this link: https://event.summitcast.com/view/oVDtKqmPn2tPc7VV7WsLAC/ACx7UpLgLXHM3BVo56spTQ. A replay will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Rafael Holdings, Inc.
Rafael Holdings, Inc. is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies that develop pharmaceuticals and medical devices. Our lead candidate is remibetadex (Trappsol® Cyclo™), for which we have completed a pivotal Phase 3 study in Niemann-Pick Disease Type C (“NPC”) and submitted an NDA to the FDA in October 2026. NPC is a rare, fatal and progressive genetic disorder. We also hold interests in other clinical-stage and early-stage pharmaceutical development companies and an orthopedic-focused medical device company.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; the FDA’s review of our NDA for remibetadex, including whether it will be accepted for filing, granted priority review or approved; our eligibility for and ability to monetize a priority review voucher; plans regarding the further evaluation of clinical data; and the potential of our pipeline. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the risk that the FDA may not accept for filing or approve our NDA, including because the Phase 3 TransportNPC™ study did not meet its primary endpoint in the overall population, our need for additional financing and the substantial doubt about our ability to continue as a going concern, and those disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended July 31, 2026, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Contact:

Barbara Ryan
barbara.ryan@rafaelholdings.com
(203) 274-2825

At the Annual General Meeting of Festi hf. held on 5 March 2026, it was resolved to authorise the Company to purchase, until the next Annual General Meeting, shares in the Company representing up to 10% of the Company’s total share capital. On the basis of the aforementioned authorisation, the Board of Directors of Festi has resolved to implement a share buyback programme for the purchase of own shares for the purpose of reducing the Company’s issued share capital and/or enabling the Company to fulfil its obligations under employee share option agreements.

The maximum aggregate amount of the share buyback is ISK 1,000 million. The maximum price payable per share may not exceed the higher of the price of the last independent trade and the highest current independent bid on the trading venues where the shares are traded.

Festi has engaged Arion Bank to manage the share buyback. The purchases will commence by way of a reverse tender offer. All shareholders of Festi may submit offers to sell their shares to the Company through Arion Bank. Festi reserves the right to accept or reject any offer, in whole or in part. Shareholders shall specify in their sell orders the number of shares offered for sale and the minimum price per share they are willing to accept. Offers will be accepted in ascending order of price until the intended amount of the buyback has been reached, subject to the applicable limits. All shares purchased by the Company will be purchased at the same price, corresponding to the highest price of the accepted sell orders.

The share buyback is carried out in accordance with Act No. 2/1995 on Public Limited Companies, Article 5 of MAR (Regulation (EU) No. 596/2014 of the European Parliament and of the Council on market abuse, which has the force of law in Iceland pursuant to Act No. 60/2021 on Measures against Market Abuse), as well as Commission Delegated Regulation (EU) 2016/1052 laying down regulatory technical standards regarding the conditions applicable to buyback programmes.

Offers shall be submitted to Arion Bank’s Capital Markets, which will also respond to enquiries, by email to verdbrefamidlun@arionbanki.is, marked “Festi endurkaup”, no later than 08:30 on 4 November 2026.

The results will be announced through the Nasdaq Iceland news system no later than 09:30 on 4 November 2026. The settlement date for accepted offers will be T+2, i.e. 6 November 2026.

Prior to the commencement of the share buyback under the reverse tender offer, Festi holds a total of 6,678,864 own shares, corresponding to 2.14% of the Company’s share capital.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.